Clinical practice and outcome of patients with elderly‐onset ulcerative colitis: Insights from a nationwide claims database study in Japan

Abstract

Abstract Background and Aim The number of older patients with ulcerative colitis is increasing; however, limited data exist regarding the differences between elderly‐ and non‐elderly‐onset ulcerative colitis. We aimed to compare the clinical practice and course of elderly‐onset ulcerative colitis with those of non‐elderly‐onset ulcerative colitis. Methods We selected older patients with ulcerative colitis and divided them into the elderly‐ and non‐elderly‐onset ulcerative colitis groups according to their age at onset. We compared the cumulative systemic steroid‐free, molecular targeting drug‐free, and surgery‐free rates between the two groups. We performed a multivariate analysis to identify the clinical factors related to systemic steroid administration, the use of molecular targeting drugs, surgery, and death. Results We collected data of 2669 and 277 elderly and non‐elderly‐onset ulcerative colitis patients, respectively. The cumulative systemic steroid‐free rate of elderly‐onset ulcerative colitis was significantly lower than that of non‐elderly‐onset ulcerative colitis. However, no difference was observed in the cumulative molecular targeting drugs and surgery‐free rates between the two groups. Elderly‐onset ulcerative colitis significantly increased the risk of systemic steroid administration and death but not the use of molecular targeting drugs and surgery. Conclusion The disease severity of ulcerative colitis and clinical practice may not differ between the elderly‐ and non‐elderly‐onset groups. However, elderly‐onset ulcerative colitis was associated with increased mortality risk. Thus, we need to pay attention to the patients' condition and appropriate timing of surgery for patients with elderly‐onset ulcerative colitis.

Keywords

• claims database
• molecular targeting drug
• older onset
• steroid
• ulcerative colitis